Data Availability
Individual patient data obtained from the eligible clinical trials analyzed in this study and any materials generated during the study are available and will be released via a material transfer agreement and study protocol, if available.
https://journal.ppcr.org/index.php/ppcrjournal/article/view/142
Posted October 28, 2021.
Matching Adjusted Indirect Comparisons (MAICs) and Systematic Review: Efficacy and Safety of Experimental Chimeric Antigen Receptor (CAR) T-cells versus Axicabtagene ciloleucel (Yescarta) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL)
